Insmed Inc. buy Truist Financial Co.
Start price
20.12.25
/
50%
€148.00
Target price
20.12.26
-
Performance (%)
-10.14%
Price
22.01.26
€133.00
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -10.14%. This prediction currently runs until 20.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.920% | -2.920% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat